Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial

Berent, 1987, Zonisamide (C1912) and cognition: results from preliminary study, Epilepsia, 28, 61, 10.1111/j.1528-1157.1987.tb03624.x

Chadwick, 1990, Gabapentin in partial epilepsy, Lancet, 335, 1114, 10.1016/0140-6736(90)91123-R

Charles, 1990, Zonisamide-induced mania, Psychosomatics, 31, 214, 10.1016/S0033-3182(90)72198-6

Commision on Classification and Terminology of teh International League against Epilepsy, 1981, Proposal for revised clinical and electroencephalographic classification of epileptic seizures, Epilepsia, 22, 489, 10.1111/j.1528-1157.1981.tb06159.x

Crawford, 1986, A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy, J. Neurol. Neurosurg. Psychiatry, 49, 644, 10.1136/jnnp.49.11.1251

Henry, 1991, Zonisamide, 423

Ito, 1980, 3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug: electroencephalographic profile, Arzneimittel-Forsch., 30, 603

Juergens, 1987, Simultaneous determination of zonisamide and nine other antiepileptic drugs and metabolism in serum. A comparison of micro and conventional high-performance liquid chromatography, J. Chromatogr., 385, 233, 10.1016/S0021-9673(01)94635-7

Kamei, 1981, Effects of 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810) and some antiepileptics on the kindled seizures in the neocortex, hippocampus and amygdala in rats, Arch. Int. Pharmacodyn. Ther., 249, 164

Leppik, 1993, Efficacy and safety of zonisamide: Results of a multicenter study, Epilepsy Res., 14, 165, 10.1016/0920-1211(93)90021-X

Loiseau, 1987, European multicenter trial of zonisamide, 73

Masuda, 1980, Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug: pharmacological profile, Arzneimittel-Forsch., 30, 477

Mumford, 1989, Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy, Br. J. Clin. Pharmacol., 27, 101S, 10.1111/j.1365-2125.1989.tb03469.x

Ojemann, 1986, Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenyton monotherapy, Ther. Drug. Monitor., 8, 293, 10.1097/00007691-198609000-00010

Sackellares, 1985, Pilot study of zonisamide (1,2 benzisoxazole-3-methansulfonamide) in patients with refractory partial seizures, Epilepsia, 26, 206, 10.1111/j.1528-1157.1985.tb05407.x

Sakamoto, 1989, Effects of zonisamide in children with epilepsy, Curr. Ther. Res., 43, 378

Sander, 1990, The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy, Epilepsy Res., 7, 226, 10.1016/0920-1211(90)90019-R

Schmidt, 1982, Two antiepileptic drugs for intractable epilepsy with complex-partial seizures, J. Neurol. Neurosurg. Psychiatry., 45, 1119, 10.1136/jnnp.45.12.1119

Seino, 1988, Efficacy evaluation of AD-810 (zonisamide): double-blind study comparing with carbamazepine, J. Clin. Exp. Med., 144, 275

Seino, 1991, Zonisamide, 169

Shimizu, 1990, Effects and side effects of zonisamide during long-term medication, Cur. Ther. Res., 47, 696

Temkin, 1986, New AEDs: are the compounds or the studies ineffective?, Epilepsia, 27, 644

Wilensky, 1985, Zonisamide in epilepsy: a pilot study, Epilepsia, 26, 212, 10.1111/j.1528-1157.1985.tb05408.x